Literature DB >> 9687385

Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.

K Riesbeck1, A Forsgren, A Henriksson, A Bredberg.   

Abstract

Exposure of cells to adverse environmental conditions invokes a genetically programmed series of events resulting in the induction of specific genes. The fluoroquinolone antibiotic ciprofloxacin has recently been reported to upregulate interleukin-2 (IL-2) gene induction. In the present investigation, the effect of ciprofloxacin at supratherapeutic concentrations on immediate-early (<2 h) gene expression in primary human peripheral blood lymphocytes was studied with Northern blots. In addition, transcriptional activity of IL-2 and metallothionein enhancer and promoter regions and transcription factors AP-1, NF-kappaB, and NF-AT were analyzed by chloramphenicol acetyltransferase (CAT) and electrophoretic mobility shift assays, respectively. The concentration of c-fos, c-jun, c-myc, junB, and fra-1 mRNAs was increased in activated peripheral blood lymphocytes incubated with ciprofloxacin compared to that in untreated controls. Ciprofloxacin increased CAT activity in stimulated lymphocytes transfected with plasmids containing either the IL-2 or metallothionein enhancer. Furthermore, among the transcription factors tested, AP-1 activity was increased in stimulated purified T helper lymphocytes incubated with ciprofloxacin compared to drug-free controls. Taken together, ciprofloxacin increased the levels of immediate-early transcripts, enhanced IL-2 and metallothionein promoter induction, and upregulated AP-1 concentrations in primary lymphocytes, reflecting a program commonly observed in mammalian stress responses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9687385      PMCID: PMC105711     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

Review 1.  Regulation of gene expression by tumor promoters.

Authors:  H J Rahmsdorf; P Herrlich
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

2.  Transcription of adenovirus and HeLa cell genes in the presence of drugs that inhibit topoisomerase I and II function.

Authors:  J Schaak; P Schedl; T Shenk
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

Review 3.  Functional role for the c-Abl protein tyrosine kinase in the cellular response to genotoxic stress.

Authors:  S Kharbanda; Z M Yuan; R Weichselbaum; D Kufe
Journal:  Biochim Biophys Acta       Date:  1997-10-24

4.  Enhancement of interleukin-2 production in human lymphocytes by two new quinolone derivatives.

Authors:  T Zehavi-Willner; I Shalit
Journal:  Lymphokine Res       Date:  1989

5.  Structure and chromosomal localization of the functional intronless human JUN protooncogene.

Authors:  K Hattori; P Angel; M M Le Beau; M Karin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

Review 6.  Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli.

Authors:  G C Walker
Journal:  Microbiol Rev       Date:  1984-03

7.  Fluorinated 4-quinolones induce hyperproduction of interleukin 2.

Authors:  K Riesbeck; J Andersson; M Gullberg; A Forsgren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Characterization of antigen receptor response elements within the interleukin-2 enhancer.

Authors:  D B Durand; J P Shaw; M R Bush; R E Replogle; R Belagaje; G R Crabtree
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

9.  4-Quinolone antibiotics: positive genotoxic screening tests despite an apparent lack of mutation induction.

Authors:  A Bredberg; M Brant; K Riesbeck; Y Azou; A Forsgren
Journal:  Mutat Res       Date:  1989-03       Impact factor: 2.433

10.  A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor.

Authors:  H R Schöler; A K Hatzopoulos; R Balling; N Suzuki; P Gruss
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  6 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Legionella pneumophila replication in macrophages inhibited by selective immunomodulatory effects on cytokine formation by epigallocatechin gallate, a major form of tea catechins.

Authors:  K Matsunaga; T W Klein; H Friedman; Y Yamamoto
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

3.  Effect of moxifloxacin on production of proinflammatory cytokines from human peripheral blood mononuclear cells.

Authors:  Jung-Hyun Choi; Min-Jin Song; Seung-Han Kim; Su-Mi Choi; Dong-Gun Lee; Jin-Hong Yoo; Wan-Shik Shin
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

4.  Antibiotic-induced release of small extracellular vesicles (exosomes) with surface-associated DNA.

Authors:  Andrea Németh; Norbert Orgovan; Barbara W Sódar; Xabier Osteikoetxea; Krisztina Pálóczi; Katalin É Szabó-Taylor; Krisztina V Vukman; Ágnes Kittel; Lilla Turiák; Zoltán Wiener; Sára Tóth; László Drahos; Károly Vékey; Robert Horvath; Edit I Buzás
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

5.  Analysis of the membrane proteome of ciprofloxacin-resistant macrophages by stable isotope labeling with amino acids in cell culture (SILAC).

Authors:  Nancy E Caceres; Maarten Aerts; Béatrice Marquez; Marie-Paule Mingeot-Leclercq; Paul M Tulkens; Bart Devreese; Françoise Van Bambeke
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

6.  Moxifloxacin modulates inflammation during murine pneumonia.

Authors:  Christoph Beisswenger; Anja Honecker; Andreas Kamyschnikow; Markus Bischoff; Thomas Tschernig; Robert Bals
Journal:  Respir Res       Date:  2014-07-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.